الاصابة بكورونا بعد اللقاح. تعرَّف على الحقائق بخصوص لقاحات كوفيد 19

COVID-19 vaccines and allergic reactions Phased allocation of COVID-19 vaccines
Moderna COVID-19 vaccine: Fact sheet for recipients and caregivers FDA takes additional action in fight against COVID-19 by issuing emergency use authorization for second COVID-19 vaccine

mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants.

التطعيم
Centers for Disease Control and Prevention
التطعيم
How CDC is making COVID-19 recommendations
تعرَّف على الحقائق بخصوص لقاحات كوفيد 19
Janssen COVID-19 vaccine: Fact sheet for recipients and caregivers
Centers for Disease Control and Prevention FDA for emergency use authorization
Vaccine adverse event reporting system VAERS Centers for Disease Control and Prevention

.

20
المناعة الطبيعية المتشكلة بعد الاصابة بكورونا والمناعة المكتسبة بعد اللقاح
COVID-19 vaccine: Frequently asked questions
التطعيم
Centers for Disease Control and Prevention
تعرَّف على الحقائق بخصوص لقاحات كوفيد 19
Moderna announces primary efficacy analysis in phase 3 COVE study for its COVID-19 vaccine candidate and filing today with the U
Janssen COVID-19 vaccine: Fact sheet for healthcare providers administering vaccine Centers for Disease Control and Prevention
When vaccine is limited, who should get vaccinated first? What to expect after getting a COVID-19 vaccine V-safe after vaccination health checker

Vaccine Adverse Event Reporting System.

التطعيم
Understanding viral vector COVID-19 vaccines
التطعيم
Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents
المناعة الطبيعية المتشكلة بعد الاصابة بكورونا والمناعة المكتسبة بعد اللقاح
COVID-19 vaccines vs variants — Determining how much immunity is enough